CS Professional · Corporate Restructuring, Valuation and Insolvency · Valuation of Business and Assets for Corporate Restructuring
Orion Pharma Ltd. is being valued for a merger. The registered valuer applies the Asset Approach, Income Approach and Market Approach and then assigns weights to the three results to reach one value per share. Which statement best reflects accepted valuation practice under ICAI Valuation Standards and the Rules for this exercise?
The valuer may use several approaches and weight them, but must disclose the methods, assumptions and the reasons for the weights in the report. No single approach is compulsory, and the weighting is a matter of the valuer's professional judgement, not the Board's.
- AOnly the Asset Approach is lawful for a listed or unlisted company in a merger
- BThe valuer may use more than one approach, and must state the methods used and the reasons for weights in the reportCorrect
- CWeights can be assigned only by the Board of Directors, not the valuer
- DThe Market Approach must be rejected whenever the company is unlisted
Explanation
Valuation standards permit and often expect use of multiple approaches, with the valuer applying judgement and disclosing the methodology, assumptions and basis of weighting in the report. No single approach is mandated for all cases, the valuer and not the Board decides weights, and the Market Approach can use comparable companies even for unlisted entities.
Did you get it right without looking?
One question tells you little. A timed set on Valuation of Business and Assets for Corporate Restructuring shows your real accuracy, how long you take and where you lose marks.
More Valuation of Business and Assets for Corporate Restructuring questions
- Meenakshi Engineering Ltd expects free cash flows to the firm of Rs 20 crore at the end of year 1, growing at a constant 5% per year forever…
- Meridian Foods Ltd's acquired customer relationships are valued by the multi-period excess earnings method. Projected after-tax cash flow at…
- In a DCF valuation of Bharat Pumps Ltd, the analyst uses the Gordon growth model for terminal value. Year 5 FCFF is Rs 200 lakh, WACC is 12%…
- Two valuers separately value the same unlisted company. One values it for a sale to a strategic buyer expecting synergies, the other for a m…
- Sundaram Auto Ltd is being valued for a merger. Its peer set trades at an average EV/EBITDA multiple of 8x. Sundaram's EBITDA is Rs 50 crore…
- Meridian Pharma Ltd is considering buying a competitor. The directors say, 'The balance sheet shows net assets of Rs 80 crore, so that is wh…